( As on 30/04/2025 10:54)
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated April 30, 2025, titled ""Zydus receives final approval from USFDA for Niacin Extended-Release Tablets USP, 500 mg, 750 mg, and 1,000 mg"".